Proc. roy. Soc. Med. Volume 65 July 1972 22 It is of interest in relation to the report of the Committee on Cancer Detection of the International Union against Cancer (Phillips et al. 1969 ) that the present study exemplifies the advantage of the immunological compared to the cytological type of cancer detection test. The latter, of course, depends upon having access to the organ thought to be involved, whereas the former does not. Thus in the Stage 1 and 2 patients positive results were seen on testing patients subsequently found to have carcinoma of the breast, ovary, bladder, prostate, larynx, colon and rectum.
On the other hand, however, a positive test should also direct attention to the exclusion of the presence of the other conditions which have so far been shown to have relatively high response rates. These are peptic ulcer, diverticulitis, ulcerative colitis and fibrocystic disease of the breast.
The present findings are generally similar to those of studies carried out in the United States (Makari 1969), Japan (Honda et al. 1972) and France (Boisivon 1972) . Including the present study, reports are now available on the results of testing in over 1,500 patients. Much work obviously remains to be carried out, but the preliminary impression must be that this test, which is now shown to involve a valid phenomenon as judged by statistical tests of significance, is likely to prove of value as a diagnostic test in patients thought to have early carcinoma. There is a great deal of interest at present in the topic 'tumour-specific antigens' and this was reflected in the three communications presented. Each speaker used a different immunological technique which he hoped would help to improve the detection ofhuman neoplasia.
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Mr E A Caspary discussed lymphocyte sensitization in malignant disease and presented his in vitro cell electrophoretic method, which showed that lymphocytes of patients with carcinomas are sensitized both to a basic protein which is related to the encephalitogenic factor extracted from normal myelin, and to a greater extent to similar small acid-extractable proteins derived from different malignant neoplasms. It was possible to separate 85 controls from 197 tumour-bearing patients. Overlap tended to occur in advanced metastatic carcinoma, possibly due to depressed immune responses. Interpretation was difficult in patients with neurological disease and diseases such as tuberculosis and sarcoidosis which are associated with hyperimmune responses of a nonspecific nature.
A difficult immunological approach was presented by Dr D E H Tee. Polysaccharides extracted from a heterogeneous group of tumours are incubated with the patients' serum and the mixture injected intradermally at 11 different sites: the resulting areas oferythema are measured two minutes later. This test was said to discriminate between patients with early carcinomas (86 % positive Stage 1; 61 % positive Stage 2) and nonneoplastic disease (21 % positive), and was considered valuable not only as a diagnostic and prognostic aid but also as an early indication of tumour development. Studies in the United States have shown that half of non-neoplastic patients showing positive results subsequently develop neoplasms.
In the ensuing discussion, it became clear that the methods described by both workers required skilled operation and interpretation and were probably not suitable for routine clinical use.
This could not be said of the third approach proposed by Dr D Thomson, who employed a radioimmunoassay to detect in plasma nanogram amounts of a glycoprotein called the carcinoembryonic antigen (CEA), which occurs in the plasma membrane of feetal gut cells and tumour cells, particularly those of endodermal origin. While preliminary studies by Dr Thomson and his group in Montreal tended to show that CEA was elevated only in the plasma of patients with colonic and rectal carcinomas, further work has revealed that a wide variety of malignant tumours of differing histogenesis can give similar results.
Unfortunately not all malignant lesions yield elevated values; these are more prone to occur once the tumour has spread beyond its initial confines. In addition, false positive results can be obtained with diseases such as ulcerative colitis and chronic renal and hepatic failure. However, this test represents the first real attempt of practical value to use tumour-associated antigens for diagnostic purposes. The interrelationship of the antigens used by each group of workers was not known and, in the final discussion period, collaboration between the various; groups was recommended so that materials and results in the same patients could be compared.
